banner
    JNJ image

    Johnson & Johnson

    JNJ

    155.38

    USD
    -2.37
    (-1.50%)
    Day's range
    154.33
    157.1
    52 wk Range
    140.68
    169.99

    Key Statistics

    Previous Close
    157.75
    Open
    156.49
    Day's Range
    154.33 - 157.1
    52 wk Range
    140.68 - 169.99
    Volume
    7.35M
    Average Volume
    9.95M
    Market Cap
    374.44B
    Shares Outstanding
    2.41B
    Revenue
    88.82B
    Net Income
    14.07B
    EPS
    8.99
    P/E Value
    17.28
    Next Earnings Date
    Jul 16, 2025
    Dividend (Yield)
    3.22%
    Return on Assets
    7.81%
    Return on Equity
    19.87%
    Gross Profit Margin
    69.07%
    Price/Book
    5.19
    EBITDA
    24.78B
    EV/EBITDA (TTM)
    15.49
    P/BV Value
    5.19
    P/S Value
    4.18
    Beta
    0.48

    Johnson & Johnson Company Profile

    Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

    Industry
    Drug Manufacturers - General
    Sector
    Healthcare
    Employes
    138100
    Market
    US